JPS6040957A - 抱合型ビリルビンの安定化法 - Google Patents
抱合型ビリルビンの安定化法Info
- Publication number
- JPS6040957A JPS6040957A JP14944183A JP14944183A JPS6040957A JP S6040957 A JPS6040957 A JP S6040957A JP 14944183 A JP14944183 A JP 14944183A JP 14944183 A JP14944183 A JP 14944183A JP S6040957 A JPS6040957 A JP S6040957A
- Authority
- JP
- Japan
- Prior art keywords
- bilirubin
- stability
- solution
- type
- conjugation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 title claims abstract description 77
- 230000006641 stabilisation Effects 0.000 title description 3
- 238000011105 stabilization Methods 0.000 title description 3
- 238000000034 method Methods 0.000 claims description 14
- 239000002736 nonionic surfactant Substances 0.000 claims description 11
- 230000000087 stabilizing effect Effects 0.000 claims description 3
- 238000008050 Total Bilirubin Reagent Methods 0.000 abstract description 12
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 abstract description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract description 6
- 238000005259 measurement Methods 0.000 abstract description 6
- 239000003638 chemical reducing agent Substances 0.000 abstract description 5
- 108010024636 Glutathione Proteins 0.000 abstract description 4
- 229940097043 glucuronic acid Drugs 0.000 abstract description 4
- 229960003180 glutathione Drugs 0.000 abstract description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 abstract description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 4
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 abstract description 3
- 239000002202 Polyethylene glycol Substances 0.000 abstract description 3
- 235000010323 ascorbic acid Nutrition 0.000 abstract description 3
- 229960005070 ascorbic acid Drugs 0.000 abstract description 3
- 239000011668 ascorbic acid Substances 0.000 abstract description 3
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 229920001223 polyethylene glycol Polymers 0.000 abstract description 3
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract description 3
- 239000004094 surface-active agent Substances 0.000 abstract description 3
- 229960003080 taurine Drugs 0.000 abstract description 3
- 206010023126 Jaundice Diseases 0.000 abstract description 2
- 239000012153 distilled water Substances 0.000 abstract description 2
- 230000002949 hemolytic effect Effects 0.000 abstract description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 abstract 1
- 206010023129 Jaundice cholestatic Diseases 0.000 abstract 1
- 241000047703 Nonion Species 0.000 abstract 1
- 201000005267 Obstructive Jaundice Diseases 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000004108 freeze drying Methods 0.000 abstract 1
- GSGDTSDELPUTKU-UHFFFAOYSA-N nonoxybenzene Chemical compound CCCCCCCCCOC1=CC=CC=C1 GSGDTSDELPUTKU-UHFFFAOYSA-N 0.000 abstract 1
- 235000019260 propionic acid Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 10
- 239000012086 standard solution Substances 0.000 description 8
- 238000008789 Direct Bilirubin Methods 0.000 description 7
- 210000002966 serum Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 235000018417 cysteine Nutrition 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000654 additive Substances 0.000 description 3
- BPYKTIZUTYGOLE-UHFFFAOYSA-N billirubin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(C=C3C(=C(C=C)C(=O)N3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-UHFFFAOYSA-N 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000004445 quantitative analysis Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- SCJLWMXOOYZBTH-BTVQFETGSA-N (2s,3s,4s,5r,6s)-6-[3-[2-[[3-[3-[(2s,3r,4s,5s,6s)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy-3-oxopropyl]-5-[(z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1h-pyrrol-2-yl]methyl]-5-[(z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-meth Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@H](O2)C(O)=O)O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@H](O2)C(O)=O)O)N1 SCJLWMXOOYZBTH-BTVQFETGSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- DQYSALLXMHVJAV-UHFFFAOYSA-M 3-heptyl-2-[(3-heptyl-4-methyl-1,3-thiazol-3-ium-2-yl)methylidene]-4-methyl-1,3-thiazole;iodide Chemical compound [I-].CCCCCCCN1C(C)=CS\C1=C\C1=[N+](CCCCCCC)C(C)=CS1 DQYSALLXMHVJAV-UHFFFAOYSA-M 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
- 239000006171 Britton–Robinson buffer Substances 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- -1 aromatic diazonium salt Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000003325 follicular Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000946 synaptic effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
- G01N33/728—Bilirubin; including biliverdin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14944183A JPS6040957A (ja) | 1983-08-15 | 1983-08-15 | 抱合型ビリルビンの安定化法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14944183A JPS6040957A (ja) | 1983-08-15 | 1983-08-15 | 抱合型ビリルビンの安定化法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6040957A true JPS6040957A (ja) | 1985-03-04 |
| JPH0154669B2 JPH0154669B2 (Direct) | 1989-11-20 |
Family
ID=15475181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14944183A Granted JPS6040957A (ja) | 1983-08-15 | 1983-08-15 | 抱合型ビリルビンの安定化法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6040957A (Direct) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0541729A4 (en) * | 1990-10-22 | 1994-09-28 | Abbott Lab | Stabilized anoxic diagnostic reagent solution |
| US5449623A (en) * | 1990-10-30 | 1995-09-12 | Wako Pure Chemical Industries, Ltd. | Method for measuring bilirubin |
| US5872009A (en) * | 1994-12-02 | 1999-02-16 | Nitto Boseki Co., Ltd. | Method for measuring bilirubin |
-
1983
- 1983-08-15 JP JP14944183A patent/JPS6040957A/ja active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0541729A4 (en) * | 1990-10-22 | 1994-09-28 | Abbott Lab | Stabilized anoxic diagnostic reagent solution |
| US5449623A (en) * | 1990-10-30 | 1995-09-12 | Wako Pure Chemical Industries, Ltd. | Method for measuring bilirubin |
| EP0686849A3 (Direct) * | 1990-10-30 | 1996-01-17 | Wako Pure Chem Ind Ltd | |
| US5563072A (en) * | 1990-10-30 | 1996-10-08 | Wako Pure Chemical Industries, Ltd. | Method for measuring bilirubin |
| US5872009A (en) * | 1994-12-02 | 1999-02-16 | Nitto Boseki Co., Ltd. | Method for measuring bilirubin |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0154669B2 (Direct) | 1989-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5989845A (en) | Diagnostic compositions and devices utilizing same | |
| US5776719A (en) | Diagnostic compositions and devices utilizing same | |
| US3485587A (en) | Protein indicator | |
| Trinder | Rapid determination of salicylate in biological fluids | |
| WO1980001389A1 (fr) | Piece d'essai pour la mesure du glucose | |
| Morin et al. | Single Glucose Oxidase—Peroxidase reagent for two-minute determination of serum glucose | |
| US5057435A (en) | Reagent and methods for calcium determination | |
| US4119401A (en) | Total bilirubin assay | |
| IE46892B1 (en) | A composition for use in determination methods | |
| JPS6040957A (ja) | 抱合型ビリルビンの安定化法 | |
| Mouw et al. | Acute effects of lead on renal electrolyte excretion and plasma renin activity | |
| JPH087208B2 (ja) | 便潜血検査試薬および方法 | |
| WO1999004258A1 (en) | Assay for total and direct bilirubin | |
| CN109164259A (zh) | 一种灵敏度高的结合珠蛋白检测试剂盒 | |
| US5096812A (en) | Assay method for gamma glutamyltransferase (GGT) in liquid blood and dried blood | |
| JP3920110B2 (ja) | 遊離脂肪酸（ｎｅｆａ）の測定用液状試薬 | |
| US4030885A (en) | Bilirubin determination | |
| US3825411A (en) | Reagent and method for bilirubin determination | |
| Beale et al. | Rapid incremental methods for the determination of serum iron and iron-binding capacity | |
| PL176625B1 (pl) | Środek stabilizujący alfaGST w moczu i sposób ilościowego oznaczania alfaGST w moczu | |
| US6379915B1 (en) | Diagnostic compositions and devices utilizing same | |
| JPS62204159A (ja) | 蛋白定量用試薬組成物 | |
| US4965210A (en) | Stable reagent for determining bilirubin in serum and method of preparation | |
| JPS59107264A (ja) | 血液中の総ビリルビンの測定法 | |
| US3348920A (en) | Reagent and method for the quantitative determination of bilirubin |